| NAME |
SAQUINAVIR 200MG (INVIRASE) CAP |
| VA GENERIC NAME |
SAQUINAVIR |
| DOSAGE FORM |
CAP,ORAL |
| FDA MED GUIDE |
Saquinavir_Mesylate_(Invirase)_(2015).pdf |
| FORMULARY DESIGNATOR TEXT |
|
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
NO |
| NATIONAL FORMULARY RESTRICTION |
Refer to HIV/AIDS TAG treatment guidelines
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
200 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2019-02-19 00:00:00 |
| UNITS |
MG |
| NATIONAL FORMULARY NAME |
SAQUINAVIR CAP,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
- COPAY END DATE: 2018-12-27 00:00:00
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2018-12-28 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
SAQUINAVIR 200MG (INVIRASE) CAP |
| VA PRODUCT IDENTIFIER |
S0261 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
CAP |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4013249 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
-
- 2019-02-19 00:00:00
- STATUS: INACTIVE
|
